Notes on the therapy of multiple sclerosis (MS)
MRI, neuroimmunology and neurobiology have provided significant contributions to the rationale of the therapeutic approach in multiple sclerosis. It is clear that the ignorance of the etiologic factor has lead to a double treatment policy: the first is aimed to control the acute phase of the disease while the second strives to block the pathogenetic mechanisms underlying the disease itself and the relapses. The author reviews and discusses the latest issues on this topic based on his own clinical and laboratory experience.